
Mark A. Lewis, MD, explains when unexpected disease behavior in neuroendocrine tumors should prompt a specialist referral and how patients can still be treated close to home.
Rozita Yarmand, PhD, discusses the take home message from the current research in medullary thyroid cancer.
Rozita Yarmand, PhD, an assistant professor in the department of endocrine neoplasia and hormonal disorders at The University of Texas MD Anderson Cancer Center, discusses
MTC requires more novel agents that are less toxic and more durable. Research in the field aims to find new novel compounds to fill this need.




